PharmacoMicrobiomics: The Drug-Microbiome Portal

How Bugs Modulate Drugs?

Launched on 11/11/11; Current Release 1.5 (21 Mar 2021): Spring of Hope! (Release History)

Detailed View

Summary Gut microbes (currently unknown members) affect Sulfinpyrazone's reduction.
Sulfinpyrazone (PubChem CID: 5342)
affect reduction
The gut microbiota reduce sulfinpyrazone, a drug used to treat gout and gouty arthritis, into sulfinpyrazone sulfide metabolite. Of note, ex vivo experiments showed that human feces reduced sulindac more extensively than sulphinpyrazone. Further in vivo experiments, which used metronidazole and tetracycline as antibiotics against anaerobic and aerobic bacteria, respectively, demonstrated that anaerobic intestinal bacteria are the key players the reduction of these sulphoxide-containing drugs.

Browse Drug-Microbiome Relationship